MENU
MENU
About Us
Statement From CEO
Our Leadership
Partnerships
Programs
Cancer Immunotherapy
SARS-CoV-2 Vaccine
Publications
News & Media
Contact Us
Contact Us
Careers
MENU
MENU
About Us
Statement From CEO
Our Leadership
Partnerships
Programs
Cancer Immunotherapy
SARS-CoV-2 Vaccine
Publications
News & Media
Contact Us
Contact Us
Careers
June 2021
AIVITA Biomedical’s Phase 2 Glioblastoma Trial Shows Improved Progression Free Survival